Published in Cancer on April 01, 1987
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol (1991) 3.45
Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol (2004) 1.77
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci U S A (2005) 1.48
LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene (2011) 1.43
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis. Gut (1992) 1.38
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer (2004) 1.19
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer (2005) 1.15
Increased expression of a Myc target gene Mina53 in human colon cancer. Am J Pathol (2004) 1.10
c-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer (1989) 1.06
Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br J Cancer (1993) 0.99
C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy. J Clin Pathol (1989) 0.97
A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. Br J Cancer (1987) 0.95
DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC. J Biol Chem (2009) 0.93
Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis. J Clin Pathol (1987) 0.93
Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation. Proc Natl Acad Sci U S A (1989) 0.90
Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis. Br J Cancer (1989) 0.89
Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells. Oncogene (2015) 0.87
Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours. J Clin Pathol (1990) 0.85
REGγ is associated with multiple oncogenic pathways in human cancers. BMC Cancer (2012) 0.84
Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer (1995) 0.83
Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer. Proc Natl Acad Sci U S A (1992) 0.80
The expression of c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung. Cancer Res Treat (2004) 0.78
The role of oncogenes in gastrointestinal cancer. Gastrointest Cancer Res (2010) 0.78
Evaluation of p62c-myc in benign and malignant gastric epithelia. Br J Cancer (1987) 0.77
C-myc oncogene expression in anal squamous neoplasia. J Clin Pathol (1993) 0.77
Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Res (2015) 0.77
The MYC 3' Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells. Cancers (Basel) (2016) 0.76
c-myc protein distribution. Neoplastic tissues of the human colon. Am J Pathol (1992) 0.76
Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer. J Clin Pathol (1998) 0.75
Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer. Cancer Biol Ther (2015) 0.75
Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis. Mol Med Rep (2016) 0.75
A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer. BMC Genomics (2017) 0.75
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
A general model for the genetic analysis of pedigree data. Hum Hered (1971) 40.17
Meta-analysis of theory-of-mind development: the truth about false belief. Child Dev (2001) 11.06
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
The analysis of quantitative traits for simple genetic models from parental, F 1 and backcross data. Genetics (1973) 6.43
Routine follow up of breast cancer in primary care: randomised trial. BMJ (1996) 5.91
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
Effect of computer support on younger women with breast cancer. J Gen Intern Med (2001) 5.12
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med (1974) 4.48
Cancer survival in Britain is poorer than that of her comparable European neighbours. BMJ (1999) 4.39
Biometrical genetics with one or two loci: the inheritance of physiological characters in mice. Genetics (1973) 4.38
Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell (1999) 4.38
Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev (1984) 4.37
Publication bias and clinical trials. Control Clin Trials (1987) 4.34
Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med (1980) 4.32
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev (1992) 4.03
Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) (1981) 3.90
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev (2000) 3.40
A license to kill. Cell (1996) 3.37
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol (1980) 3.28
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
Generic inhalers for asthma. BMJ (1994) 3.09
Characteristics of human herpesvirus-6. J Infect Dis (1988) 3.02
Apoptosis in development. Nature (2000) 2.95
Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A (1990) 2.88
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. J Immunol (1979) 2.79
A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77
CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med (1995) 2.70
A comparison of lumbar epidural and intravenous fentanyl infusions for post-thoracotomy analgesia. Can J Anaesth (1994) 2.67
New guidelines for urgent referral of patients with cancer are waste of energy. BMJ (2000) 2.66
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J (1985) 2.53
A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A (1996) 2.52
The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol (1978) 2.43
Mechanism of processivity clamp opening by the delta subunit wrench of the clamp loader complex of E. coli DNA polymerase III. Cell (2001) 2.39
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Randomized trial of periportal peritoneal bupivacaine for pain relief after laparoscopic cholecystectomy. Br J Surg (1996) 2.33
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev (1999) 2.31
The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis. J Exp Med (1973) 2.30
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A (1993) 2.28
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet (1991) 2.26
Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract (1999) 2.24
Interleukin 2: a class of T cell growth factors. Immunol Rev (1980) 2.21
Social costs of untreated opioid dependence. J Urban Health (2000) 2.18
WHO collaborative study on the sero-epidemiology of rubella. Bull World Health Organ (1967) 2.17
Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation (1993) 2.17
A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci (1999) 2.16
Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology (2000) 2.14
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology (2004) 2.09
Cetrimide lavage: ineffective and potentially toxic. Ann R Coll Surg Engl (1991) 2.07
Amino acid changes in conserved regions of the beta-subunit of Escherichia coli RNA polymerase alter transcription pausing and termination. Genes Dev (1990) 2.06
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene (1994) 2.05
A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2001) 2.03
Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry (2002) 2.02
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Antimicrobial properties of plant essential oils and essences against five important food-borne pathogens. Lett Appl Microbiol (1998) 1.97
Capture PCR: efficient amplification of DNA fragments adjacent to a known sequence in human and YAC DNA. PCR Methods Appl (1991) 1.96
The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. J Immunol (1979) 1.95
The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
Research Governance: a barrier to ethical research? QJM (2004) 1.89
Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.88
Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84
Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) (1996) 1.83
Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res (2000) 1.83
Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med (1990) 1.82
Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology (Berl) (1995) 1.82
Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis. Breast Cancer Res Treat (1982) 1.81
Gene therapy for cancer. Lancet (1992) 1.81
Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 1.81
Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications--a randomized clinical trial. Crit Care Med (2000) 1.79
Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. J Immunol (1980) 1.79
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect (2007) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J (1996) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis (1996) 1.69
Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol (1988) 1.67
The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol (1977) 1.64